Private Advisor Group’s Medicus Pharma Warrant MDCXW Stock Holding History

Private Advisor Group’s Portfolio MDCXW Stock Details MDCXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-49,000	Closed	-$27.4K	–	2951
2026 Q1	$27.4K	Hold	49,000	–	–	﹤0.01%	2609
2025 Q4	$39.2K	Buy	49,000 +5,000	+11%	+$4.67K	﹤0.01%	2534
2025 Q3	$31.7K	Buy	44,000 +5,000	+13%	+$4.31K	﹤0.01%	2478
2025 Q2	$34.5K	Buy	39,000 +24,000	+160%	+$25.5K	﹤0.01%	2371
2025 Q1	$10.5K	Buy	+15,000	New	+$15.6K	﹤0.01%	2285

Other funds holding MDCXW

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Private Advisor Group's MDCXW Position: Q2 2026 in Review

Private Advisor Group sold out of Medicus Pharma Warrant (MDCXW) in Q2 2026, closing a stake of 49,000 shares — an estimated $27.4K sold.

Private Advisor Group first reported a position in MDCXW in Q1 2025 and held it in 5 quarters. The position peaked at $39.2K in Q4 2025. 4 funds tracked by Wall St. Rank hold MDCXW as of Q2 2026.

Private Advisor Group reported no remaining Medicus Pharma Warrant position as of Q2 2026 after selling out during the quarter.
Private Advisor Group sold 49,000 Medicus Pharma Warrant shares in Q2 2026, an estimated $27.4K.
Private Advisor Group first reported a position in Medicus Pharma Warrant in Q1 2025 and held it in 5 quarters.
Private Advisor Group's Medicus Pharma Warrant position peaked at $39.2K in Q4 2025.
4 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.